Apellis Pharmaceuticals, Inc.
COMPLEMENT INHIBITOR DOSING REGIMENS

Last updated:

Abstract:

Methods and compositions for inhibiting complement are described.

Status:
Application
Type:

Utility

Filling date:

17 Jul 2020

Issue date:

8 Sep 2022